Physician profile
Benjamin Goldstein
NPI 1578978383
$2,010.65
in general payments reported to CMS, 2019-2025
17 companies · $243 in 2025
The $243 reported for 2025 was more than what 83% of Hospice and Palliative Medicine (Internal Medicine) providers received nationally (typical 2025 total: $77.77).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $51.36 · 2021: $191 · 2022: $113 · 2023: $512 · 2024: $277 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,031.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $623.57 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $301.99 | 2023-2025 | Tezspire, Farxiga |
| Abbvie INC. | $277.06 | 2021-2025 | |
| Glaxosmithkline, LLC. | $200.27 | 2022-2025 | Arexvy |
| Grifols USA, LLC | $161.25 | 2023 | Prolastin-C Liquid |
| E.R. Squibb & Sons, L.L.C. | $120.05 | 2024 | Eliquis |
| Boston Scientific Corporation | $87.08 | 2023 | Watchman Access System |
| Vapotherm INC | $51.36 | 2020 | |
| Janssen Biotech, INC. | $30.49 | 2025 | Rybrevant |
| Biodelivery Sciences International, INC. | $29.78 | 2021 | |
| Exelixis INC. | $27.13 | 2025 | Cabometyx |
| Hartmann USA, INC. | $21.79 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.75 | 2021 | |
| Pfizer INC. | $19.53 | 2021 | |
| Novo Nordisk INC | $14.86 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11.89 | 2021 | |
| Dynavax Technologies Corporation | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.